Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan in Worsening Congestive Heart Failure
NCT00071331Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Sep 2003
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 18
01
Overview
Phase 3, randomised, double-blind trial in congestive heart failure (CHF) comparing Tolvaptan with Placebo (2 arms). Primary endpoints: All-cause mortality and Cardiovascular death or hospitalization for heart failure. Started Sep 2003; status: completed.
02
Drugs
tolvaptan
03
Conditions
congestive heart failure (CHF)
Beyond the preview
Go deeper on NCT00071331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00071331.